Skip to main content
. 2022 Apr 28;11(9):2475. doi: 10.3390/jcm11092475

Figure 2.

Figure 2

FGFR2/3 fusion subtypes distribution (A) and prevalence of co-existing EGFR sensitizing mutations (B) in aNSCLC in the GH electronic database. Abbreviations: aNSCLC—advanced non-small cell lung cancer; EGFR—epidermal growth factor receptor; FGFR—fibroblast growth factor receptor; GH—Guardant Health.